Regulus Therapeutics Inc. Gains 136.8%
Wed, Apr 30, 2025 at 07:42 PM
Regulus Therapeutics Inc. (RGLS:NASDAQ) rocketted at $7.98, a gain of 136.8%. On Wed, Apr 30, 2025, RGLS:NASDAQ hit a New 2-Week High of $7.98. The stock appeared on our News Catalysts scanner on Wed, Apr 30, 2025 at 05:44 PM in the 'ACQUISITION' category. From Wed, Apr 16, 2025, the stock recorded 66.67% Up Days and 50.00% Green Days
About Regulus Therapeutics Inc. (RGLS:NASDAQ)
Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.
Top 10 Gainers:
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 136.8%
- Nvni Group Limited (NVNI:NASDAQ), 111.22%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 89.87%
- Jeffs' Brands Ltd (JFBR:NASDAQ), 75.29%
- Ruanyun Edai Technology Inc. (RYET:NASDAQ), 62.72%
- Rocky Brands, Inc. (RCKY:NASDAQ), 53.33%
- INVO Fertility Inc Com Par $0.0001 2025 (IVF:NASDAQ), 48.45%
- System1 Inc. Class A (SST:NYSE), 43.45%
- Above Food Ingredients Inc. (ABVE:NASDAQ), 32.06%
- Urgent.ly Inc. (ULY:NASDAQ), 30.59%